翰思艾泰生物(3378)香港公开发售超额认购3074倍 基石投资者认购15.93% 拟于12月...

新浪财经
Dec 22

来源:新浪港股-好仓工作室翰思艾泰生物医药科技(武汉)股份有限公司(股份代号:3378,股份简称:HANXBIO-B)公布全球发售结果,最终发售价定为每股32.00港元。本次全球发售共发行18,321,000股H股,其中香港公开发售占10%,即1,832,100股,国际配售占90%,即16,488,900股,超额配售权未获行使。按最终发售价计算,本次发行所得款项总额约5.9亿港元,扣除预计上市开支...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10